1. Dawson MA, Polizzotto MN, Gordon A, et al. Extramedullary relapse of multiple myeloma presenting as hematemesis and melena. Nat Clin Pract Oncol. 2006; 3:223–226.
2. Rene CG, Achiam MP, Salomo M, et al. Extramedullary relapse in a patient with multiple myeloma: a rare cause of gastrointestinal perforation and massive bleeding. BMJ Case Rep. 2021; 14:e243663.
3. Bladé J, Beksac M, Caers J, et al. Extramedullary disease in multiple myeloma: a systematic literature review. Blood Cancer J. 2022; 12:45.
4. Bansal R, Rakshit S, Kumar S. Extramedullary disease in multiple myeloma. Blood Cancer J. 2021; 11:161.
5. Benusiglio PR, McKee TA, Montet X, et al. Gastrointestinal relapse of multiple myeloma and sustained response to lenalidomide: a case report. J Med Case Rep. 2011; 5:110.
6. Yasar B, Gunes P, Guler O, et al. Extramedullary relapse of multiple myeloma presenting as massive upper gastrointestinal bleeding: a rare complication. Korean J Intern Med. 2015; 30:538–539.
7. Gagelmann N, Eikema DJ, Iacobelli S, et al. Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT. Haematologica. 2018; 103:890–897.
8. Touzeau C, Moreau P. How I treat extramedullary myeloma. Blood. 2016; 127:971–976.
9. Deng S, Xu Y, An G, et al. Features of extramedullary disease of multiple myeloma: high frequency of p53 deletion and poor survival: a retrospective single-center study of 834 cases. Clin Lymphoma Myeloma Leuk. 2015; 15:286–291.
10. Jung K, Park MI, Kim SE, et al. Borrmann type 4 advanced gastric cancer: focus on the development of scirrhous gastric cancer. Clin Endosc. 2016; 49:336–345.